IRCT20150202020908N2已完成2 期
Evaluation of interaction of mTOR signaling pathway and improvement of symptoms in osteoarthritis patients treated with metformin
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 no limit（—）
- 性别
- All
入选标准
- •Inflammatory osteoarthritis
排除标准
- •Autoimmune disease
- •Age under 18 years old
- •Inflammatory bowel disease
- •Diabetes mellitus
研究者
相似试验
尚未招募
不适用
Efficacy of therapeutic drug monitoring of mTOR inhibitor (Everolimus) in patients with renal cell carcinomaMetastatic renal cell carcinomaJPRN-UMIN000011893Osaka General Medical Center20
已完成
不适用
The project to investigate mTOR inhibitor-induced immune modulation in subjects with renal cell cancer.advanced renal cell carcinomaJPRN-UMIN000009662Departmentof Urology, Faculty of Life Sciences, Kumamoto University30
进行中（未招募）
不适用
The Role of mTOR (Mammalian Target of Rapamycin) Signaling Pathway in the Antidepressive Effect of Ketamine in Patients with Depressive Disorder.EUCTR2013-000952-17-CZPrague Psychiatric Centre
招募中
1 期
Study on the mechanism of endovascular therapy combined with acupuncture to improve the daily status of thin endometrial transplantatioThin endometriumITMCTR2000004210The Hospital Affiliated of Shandong University of Traditional Chinese Medicine
进行中（未招募）
1 期
Targeting mTOR with everolimus and/or physical training for preventing postmenopausal bone loss and accelerated skeletal aging. The RapaLoad study.CTIS2023-508093-28-00Odense University Hospital136